vs

Side-by-side financial comparison of CVRx, Inc. (CVRX) and Maison Solutions Inc. (MSS). Click either name above to swap in a different company.

Maison Solutions Inc. is the larger business by last-quarter revenue ($27.6M vs $16.0M, roughly 1.7× CVRx, Inc.). Maison Solutions Inc. runs the higher net margin — -18.0% vs -74.5%, a 56.5% gap on every dollar of revenue. On growth, CVRx, Inc. posted the faster year-over-year revenue change (4.4% vs -10.9%). Over the past eight quarters, Maison Solutions Inc.'s revenue compounded faster (42.5% CAGR vs 22.0%).

CVRx, Inc. is a commercial-stage medical technology company specializing in neuromodulation therapies for chronic cardiovascular diseases. Its flagship Barostim system treats heart failure and resistant hypertension, with core markets across North America and Europe, serving patients unresponsive to conventional drug treatments.

Maison Solutions Inc. is a specialty home goods retail company that provides a diverse portfolio of stylish, affordably priced furniture, home decor items, and daily household products. Its primary market is the Guangdong-Hong Kong-Macao Greater Bay Area in China, serving mass consumers through both offline physical stores and online e-commerce channels.

CVRX vs MSS — Head-to-Head

Bigger by revenue
MSS
MSS
1.7× larger
MSS
$27.6M
$16.0M
CVRX
Growing faster (revenue YoY)
CVRX
CVRX
+15.4% gap
CVRX
4.4%
-10.9%
MSS
Higher net margin
MSS
MSS
56.5% more per $
MSS
-18.0%
-74.5%
CVRX
Faster 2-yr revenue CAGR
MSS
MSS
Annualised
MSS
42.5%
22.0%
CVRX

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CVRX
CVRX
MSS
MSS
Revenue
$16.0M
$27.6M
Net Profit
$-11.9M
$-5.0M
Gross Margin
86.3%
23.4%
Operating Margin
-69.8%
-4.9%
Net Margin
-74.5%
-18.0%
Revenue YoY
4.4%
-10.9%
Net Profit YoY
-12.0%
-1840.5%
EPS (diluted)
$-0.45
$-0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVRX
CVRX
MSS
MSS
Q4 25
$16.0M
$27.6M
Q3 25
$14.7M
$27.2M
Q2 25
$13.6M
$34.4M
Q1 25
$12.3M
$32.3M
Q4 24
$15.3M
$29.4M
Q3 24
$13.4M
$28.2M
Q2 24
$11.8M
$16.9M
Q1 24
$10.8M
$13.6M
Net Profit
CVRX
CVRX
MSS
MSS
Q4 25
$-11.9M
$-5.0M
Q3 25
$-12.9M
$-1.5M
Q2 25
$-14.7M
$-287.4K
Q1 25
$-13.8M
$1.0M
Q4 24
$-10.7M
$-256.0K
Q3 24
$-13.1M
$700.9K
Q2 24
$-14.0M
$-2.8M
Q1 24
$-22.2M
$-549.0K
Gross Margin
CVRX
CVRX
MSS
MSS
Q4 25
86.3%
23.4%
Q3 25
86.8%
24.1%
Q2 25
84.3%
9.5%
Q1 25
83.5%
21.8%
Q4 24
83.2%
26.9%
Q3 24
83.2%
28.9%
Q2 24
83.9%
13.0%
Q1 24
85.0%
23.4%
Operating Margin
CVRX
CVRX
MSS
MSS
Q4 25
-69.8%
-4.9%
Q3 25
-83.5%
0.7%
Q2 25
-105.8%
-15.9%
Q1 25
-108.8%
3.7%
Q4 24
-67.0%
3.2%
Q3 24
-97.3%
7.3%
Q2 24
-118.3%
-14.4%
Q1 24
-206.4%
-2.3%
Net Margin
CVRX
CVRX
MSS
MSS
Q4 25
-74.5%
-18.0%
Q3 25
-87.6%
-5.7%
Q2 25
-108.4%
-0.8%
Q1 25
-111.5%
3.1%
Q4 24
-69.4%
-0.9%
Q3 24
-98.0%
2.5%
Q2 24
-118.8%
-16.4%
Q1 24
-206.0%
-4.0%
EPS (diluted)
CVRX
CVRX
MSS
MSS
Q4 25
$-0.45
$-0.23
Q3 25
$-0.49
$-0.08
Q2 25
$-0.57
$-0.02
Q1 25
$-0.53
$0.06
Q4 24
$-0.39
$-0.01
Q3 24
$-0.57
$0.04
Q2 24
$-0.65
$-0.16
Q1 24
$-1.04
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVRX
CVRX
MSS
MSS
Cash + ST InvestmentsLiquidity on hand
$75.7M
Total DebtLower is stronger
$2.6M
Stockholders' EquityBook value
$39.3M
$11.6M
Total Assets
$104.8M
$75.4M
Debt / EquityLower = less leverage
0.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVRX
CVRX
MSS
MSS
Q4 25
$75.7M
Q3 25
$85.1M
$1.1M
Q2 25
$95.0M
$775.4K
Q1 25
$102.7M
$445.4K
Q4 24
$105.9M
$355.7K
Q3 24
$100.2M
$588.9K
Q2 24
$70.4M
$2.1M
Q1 24
$80.1M
$9.4M
Total Debt
CVRX
CVRX
MSS
MSS
Q4 25
$2.6M
Q3 25
$2.6M
Q2 25
$2.6M
Q1 25
Q4 24
Q3 24
$2.5M
Q2 24
$2.6M
Q1 24
$2.6M
Stockholders' Equity
CVRX
CVRX
MSS
MSS
Q4 25
$39.3M
$11.6M
Q3 25
$48.1M
$10.1M
Q2 25
$57.9M
$11.7M
Q1 25
$71.1M
$12.0M
Q4 24
$71.1M
$10.9M
Q3 24
$65.2M
$11.2M
Q2 24
$55.2M
$10.5M
Q1 24
$66.3M
$13.3M
Total Assets
CVRX
CVRX
MSS
MSS
Q4 25
$104.8M
$75.4M
Q3 25
$111.3M
$73.3M
Q2 25
$119.6M
$77.4M
Q1 25
$129.6M
$82.7M
Q4 24
$133.4M
$82.7M
Q3 24
$127.7M
$82.1M
Q2 24
$96.0M
$82.4M
Q1 24
$106.2M
$44.2M
Debt / Equity
CVRX
CVRX
MSS
MSS
Q4 25
0.22×
Q3 25
0.26×
Q2 25
0.22×
Q1 25
Q4 24
Q3 24
0.23×
Q2 24
0.24×
Q1 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVRX
CVRX
MSS
MSS
Operating Cash FlowLast quarter
$-9.8M
$-1.7M
Free Cash FlowOCF − Capex
$-9.8M
FCF MarginFCF / Revenue
-61.3%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVRX
CVRX
MSS
MSS
Q4 25
$-9.8M
$-1.7M
Q3 25
$-9.7M
$1.1M
Q2 25
$-7.9M
$-1.6M
Q1 25
$-12.8M
$1.7M
Q4 24
$-8.0M
$1.1M
Q3 24
$-10.4M
$3.6M
Q2 24
$-9.8M
$-2.6M
Q1 24
$-10.9M
$-1.4M
Free Cash Flow
CVRX
CVRX
MSS
MSS
Q4 25
$-9.8M
Q3 25
$-10.0M
Q2 25
$-8.0M
Q1 25
$-12.9M
Q4 24
$-8.1M
Q3 24
$-10.4M
Q2 24
$-10.2M
Q1 24
$-11.8M
FCF Margin
CVRX
CVRX
MSS
MSS
Q4 25
-61.3%
Q3 25
-68.1%
Q2 25
-59.2%
Q1 25
-104.3%
Q4 24
-52.5%
Q3 24
-78.1%
Q2 24
-86.3%
Q1 24
-109.7%
Capex Intensity
CVRX
CVRX
MSS
MSS
Q4 25
0.4%
Q3 25
2.0%
Q2 25
0.8%
Q1 25
0.9%
Q4 24
0.3%
Q3 24
0.3%
Q2 24
3.0%
Q1 24
8.5%
Cash Conversion
CVRX
CVRX
MSS
MSS
Q4 25
Q3 25
Q2 25
Q1 25
1.66×
Q4 24
Q3 24
5.12×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVRX
CVRX

US$14.9M93%
Other$1.1M7%

MSS
MSS

Perishables$14.4M52%
Nonperishables$13.2M48%

Related Comparisons